Search for: "Bayer Laboratories, Inc."
Results 101 - 120
of 161
Sorted by Relevance
|
Sort by Date
8 Nov 2007, 9:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalIP Think Tank top five's: (IP Think Tank),More on IP law in the virtual world: (VirtualLaw), Interesting times for the Citi brand: (IAM), Velcro has won control of the domain name velcro.biz: (OUT-LAW), The Economic Value of Patent 'Trolls': (IP Think Tank),Industry Trilateral group and the 'global patent application' project: (PatentDocs), Update on the BitTorrent war -… [read post]
6 Jul 2009, 4:54 pm
They are seeking to revive an antitrust lawsuti against brand-name drugmaker, Bayer AG, and its U.S. subsidiary, Bayer Corp., and a generic manufacturer, Barr Laboratories, Inc., along with Barr’s business partners who challenged Bayer, leading to the “reverse payments” deal. [read post]
27 Aug 2011, 7:55 pm
Unigene Laboratories v. [read post]
7 Mar 2011, 12:02 pm
., Inc., v. [read post]
2 Jun 2011, 12:46 pm
Bayer Corp., ___ F.3d ___, 2011 WL 1938428, at *5-6 (7th Cir. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
24 Jan 2020, 10:24 am
Also tagged in this scheme were Novartis, Dendreon, Onyx, Questcor, and Bayer. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India… [read post]
26 Aug 2009, 9:20 am
"); Bayer Schering Pharma AG v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
3 Mar 2016, 5:19 am
Wyeth Laboratories, Inc. [read post]
21 Feb 2014, 8:53 am
Mylan, Inc., 911 F. [read post]
19 May 2011, 9:12 pm
In Abbott Laboratories v. [read post]
3 Jul 2008, 7:26 pm
Abbott Laboratories, 568 F. [read post]
6 Dec 2010, 2:36 am
Johnson & Johnson (Kluwer) EWHC (Pat) finds no infringement of coronary stent patents: Abbott Laboratories Limited v. [read post]
29 Jun 2011, 5:00 am
Bayer Cropscience, Inc., ___ S.W.3d ___, 2011 WL 2184317, at *10-13 (Tenn. [read post]
1 Aug 2012, 5:01 am
Anti-Doping Agency, Inc., 2008 WL 2567657, *1 (N.D.Fla. [read post]
27 May 2010, 3:40 pm
Whitehall Laboratories, Inc., 874 F. [read post]
